quantisnow
FeedTopReportsPricing
⌘K
Live feed
11:44:00·55d
PRRelease
AtaiBeckley Inc. logo
Definium Therapeutics Inc. logo
GH Research PLC logo
+2

Psychedelic Biotechs Push Toward Phase 3: Five Companies Advancing CNS Treatments

ATAI· AtaiBeckley Inc.DFTX· Definium Therapeutics Inc.GHRS· GH Research PLCHELP· Cybin Inc.LBRX· LB Pharmaceuticals Inc
Health Care
Original source

Companies

  • ATAI
    AtaiBeckley Inc.
    Health Care
  • DFTX
    Definium Therapeutics Inc.
    Health Care
  • GHRS
    GH Research PLC
    Health Care
  • HELP
    Cybin Inc.
    Health Care
  • LBRX
    LB Pharmaceuticals Inc
    Health Care

Recent analyst ratings

  • Apr 17DFTXUpdateStifel$30.00
  • Apr 13HELPUpdateTD Cowen$8.00
  • Apr 10LBRXUpdateCraig Hallum$36.00
  • Apr 10DFTXUpdatePiper Sandler$49.00
  • Mar 27ATAIUpdateDeutsche Bank$12.00
  • Feb 24DFTXUpdateWolfe Research$25.00

Related

  • SEC8h
    SEC Form 6-K filed by Cybin Inc.
  • SEC9h
    SEC Form DEFA14A filed by LB Pharmaceuticals Inc
  • SEC9h
    SEC Form DEF 14A filed by LB Pharmaceuticals Inc
  • PR17h
    Helus Pharma Strengthens Scientific Advisory Board with Addition of Dr. Robert Langer and Dr. Stephen Brannan
  • INSIDER1d
    SEC Form 4 filed by Craig Kevin James
  • SEC1d
    Amendment: SEC Form SCHEDULE 13G/A filed by Cybin Inc.
  • SEC1d
    SEC Form DEFA14A filed by AtaiBeckley Inc.
  • SEC1d
    SEC Form DEF 14A filed by AtaiBeckley Inc.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022